180 Life Sciences Corp. – NASDAQ:ATNF

180 Life Sciences Corp. stock price today

$7.3
+5.14
+239.52%
Financial Health
0
1
2
3
4
5
6
7
8
9

180 Life Sciences Corp. stock price monthly change

+0.94%
month

180 Life Sciences Corp. stock price quarterly change

+0.94%
quarter

180 Life Sciences Corp. stock price yearly change

+933.65%
year

180 Life Sciences Corp. key metrics

Market Cap
3.61M
Enterprise value
N/A
P/E
-0.07
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
0.09
PEG ratio
N/A
EPS
-41.58
Revenue
N/A
EBITDA
-10.65M
Income
-16.24M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

180 Life Sciences Corp. stock price history

180 Life Sciences Corp. stock forecast

180 Life Sciences Corp. financial statements

180 Life Sciences Corp. (NASDAQ:ATNF): Profit margin
Jun 2023 0 -3.68M
Sep 2023 0 -10.26M
Dec 2023 166.03K -1.22M -739.09%
Mar 2024 0 -1.06M
180 Life Sciences Corp. (NASDAQ:ATNF): Analyst Estimates
2025 16.64M -21.60M -129.84%
2026 30.41M 21.60M 71.05%
  • Analysts Price target

  • Financials & Ratios estimates

180 Life Sciences Corp. (NASDAQ:ATNF): Debt to assets
Jun 2023 13666714 6.95M 50.86%
Sep 2023 4958085 5.10M 103.01%
Dec 2023 5259476 5.38M 102.43%
Mar 2024 3441740 4.39M 127.73%
180 Life Sciences Corp. (NASDAQ:ATNF): Cash Flow
Jun 2023 -3.11M 640.39K 2.46M
Sep 2023 -1.77M -4.85M 2.44M
Dec 2023 -2.16M 4.21M 1.46M
Mar 2024 -1.03M 0 -264.39K

180 Life Sciences Corp. alternative data

180 Life Sciences Corp. (NASDAQ:ATNF): Employee count
Aug 2023 5
Sep 2023 5
Oct 2023 5
Nov 2023 5
Dec 2023 5
Jan 2024 5
Feb 2024 5
Mar 2024 5
Apr 2024 5
May 2024 4
Jun 2024 4
Jul 2024 4

180 Life Sciences Corp. other data

6.75% -2.13%
of ATNF is owned by hedge funds
132.18K -41.66K
shares is hold by hedge funds

180 Life Sciences Corp. (NASDAQ:ATNF): Insider trades (number of shares)
Period Buy Sel
May 2023 77244 0
Jun 2023 18000 0
Dec 2023 25000 25000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
FELDMANN MARC director
Common Stock 25,000 $0.19 $4,700
Purchase
WOODY JAMES N. director, officer.. Common Stock 25,000 $0.19 $4,700
Purchase
STEINMAN LAWRENCE director
Common Stock 18,000 $1.23 $22,068
Purchase
MCGOVERN JR. DONALD A. director
Common Stock 10,000 $1.15 $11,470
Purchase
MCGOVERN JR. DONALD A. director
Common Stock 5,000 $1.16 $5,800
Purchase
MARRONE PAMELA G director Common Stock 7,082 $1.06 $7,507
Purchase
PAMIR OZAN officer: CFO
Common Stock 5,162 $1.01 $5,214
Purchase
MCGOVERN JR. DONALD A. director
Common Stock 10,000 $1.05 $10,500
Purchase
WOODY JAMES N. director, officer.. Common Stock 40,000 $1.03 $41,200
Purchase
VU QUAN ANH officer: COO / Chief Business O..
Common Stock 8,000 $3.98 $31,840
Insider Compensation
Dr. Jonathan B. Rothbard Ph.D. (1952) Chief Scientific Officer $333,970
Mr. Ozan Pamir C.F.A. (1992) Interim Chief Financial Officer & Sec.
$299,750
Dr. James N. Woody M.D., Ph.D. (1942) Chief Executive Officer & Director $265,170
Friday, 27 December 2024
accesswire.com
Thursday, 12 December 2024
accesswire.com
Wednesday, 4 December 2024
accesswire.com
Tuesday, 29 October 2024
accesswire.com
Wednesday, 16 October 2024
accesswire.com
Wednesday, 9 October 2024
accesswire.com
Thursday, 3 October 2024
accesswire.com
Thursday, 12 September 2024
globenewswire.com
Tuesday, 30 July 2024
globenewswire.com
Tuesday, 2 July 2024
globenewswire.com
Thursday, 14 March 2024
globenewswire.com
Monday, 26 February 2024
globenewswire.com
Monday, 4 December 2023
globenewswire.com
Tuesday, 28 November 2023
globenewswire.com
Monday, 14 August 2023
globenewswire.com
Thursday, 10 August 2023
globenewswire.com
Wednesday, 9 August 2023
InvestorPlace
Sunday, 21 May 2023
PennyStocks
Friday, 19 May 2023
PennyStocks
Monday, 9 January 2023
PennyStocks
Friday, 6 January 2023
PennyStocks
Saturday, 31 December 2022
PennyStocks
Saturday, 24 December 2022
InvestorPlace
Monday, 19 December 2022
Pulse2
Wednesday, 15 June 2022
Benzinga
Monday, 31 January 2022
Pulse2
Tuesday, 28 December 2021
GlobeNewsWire
Friday, 10 December 2021
PennyStocks
Thursday, 18 November 2021
Pulse2
GlobeNewsWire
  • What's the price of 180 Life Sciences Corp. stock today?

    One share of 180 Life Sciences Corp. stock can currently be purchased for approximately $7.3.

  • When is 180 Life Sciences Corp.'s next earnings date?

    Unfortunately, 180 Life Sciences Corp.'s (ATNF) next earnings date is currently unknown.

  • Does 180 Life Sciences Corp. pay dividends?

    No, 180 Life Sciences Corp. does not pay dividends.

  • How much money does 180 Life Sciences Corp. make?

    180 Life Sciences Corp. has a market capitalization of 3.61M.

  • What is 180 Life Sciences Corp.'s stock symbol?

    180 Life Sciences Corp. is traded on the NASDAQ under the ticker symbol "ATNF".

  • What is 180 Life Sciences Corp.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of 180 Life Sciences Corp.?

    Shares of 180 Life Sciences Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are 180 Life Sciences Corp.'s key executives?

    180 Life Sciences Corp.'s management team includes the following people:

    • Dr. Jonathan B. Rothbard Ph.D. Chief Scientific Officer(age: 73, pay: $333,970)
    • Mr. Ozan Pamir C.F.A. Interim Chief Financial Officer & Sec.(age: 33, pay: $299,750)
    • Dr. James N. Woody M.D., Ph.D. Chief Executive Officer & Director(age: 83, pay: $265,170)
  • How many employees does 180 Life Sciences Corp. have?

    As Jul 2024, 180 Life Sciences Corp. employs 4 workers, which is 20% less then previous quarter.

  • When 180 Life Sciences Corp. went public?

    180 Life Sciences Corp. is publicly traded company for more then 8 years since IPO on 27 Jun 2017.

  • What is 180 Life Sciences Corp.'s official website?

    The official website for 180 Life Sciences Corp. is 180lifesciences.com.

  • Where are 180 Life Sciences Corp.'s headquarters?

    180 Life Sciences Corp. is headquartered at Building 4, Palo Alto, CA.

  • How can i contact 180 Life Sciences Corp.?

    180 Life Sciences Corp.'s mailing address is Building 4, Palo Alto, CA and company can be reached via phone at +65 05070669.

180 Life Sciences Corp. company profile:

180 Life Sciences Corp.

180lifesciences.com
Exchange:

NASDAQ

Full time employees:

4

Industry:

Biotechnology

Sector:

Healthcare

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Building 4
Palo Alto, CA 94306

CIK: 0001690080
ISIN: US68236V3024
CUSIP: 68236V104